Obstetric outcomes after medroxyprogesterone acetate treatment for early stage endometrial cancer or atypical endometrial hyperplasia: a single hospital-based study
CONCLUSION: Pregnancy after MPA therapy is associated with a high risk of placenta accreta. In cases in which the frequency of D&C is high, placenta accreta should be considered.PMID:36662363 | DOI:10.1007/s10147-023-02297-y
Source: Cancer Control - Category: Cancer & Oncology Authors: Maki Oishi Yoshifumi Kasuga Yuka Fukuma Asuka Hamuro Junko Tamai Yuya Tanaka Keita Hasegawa Takuma Yoshimura Satoru Ikenoue Daigo Ochiai Wataru Yamagami Mamoru Tanaka Source Type: research
More News: Cancer | Cancer & Oncology | Endometrial Cancer | Medroxyprogesterone | OBGYN | Perinatology & Neonatology | Pregnancy | Study | Women